T ransition from compensated hypertrophy to decompensated hypertrophy represents a key step in the development of heart failure. 1,2 One of the hallmarks of this transition is the decreased strength of cardiac contraction. 1, 3 In heart cells, the contraction is initiated by periodic transient increases in intracellular Ca 2+ . During each Ca 2+ transient, the Ca 2+ influx through L-type Ca 2+ channels (LCCs) in the cell membrane and transverse tubules (TTs) triggers Ca 2+ release from ryanodine receptors (RyRs) in the sarcoplasmic reticulum (SR). [4] [5] [6] [7] The structural integrity of the LCC-RyR signaling apparatus relies on a TT-SR linker protein, known as junctophilin-2 (JP2), 8-10 which is downregulated in all tested animal models and human specimens of decompensated hypertrophy and heart failure. [10] [11] [12] [13] [14] Recently, we found that microRNA (miR)-24, a miR that suppresses JP2 expression, is upregulated in hypertrophy/heart failure. 15 Because overexpression of miR-24 suppresses both JP2 expression and excitation-contraction (E-C) coupling efficiency, 15 we hypothesized that miR-24 upregulation is a key factor in the transition from compensated hypertrophy to heart failure.
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of the TAC groups, we suppressed the expression of miR-24 by periodic injection (Online Figure I) of a chemically modified antisense oligonucleotide antagomir 16 specific for miR-24. An oligonucleotide with mismatches to miR-24 was injected into another TAC group for negative control (NC). Single cardiomyocytes were isolated around 30 weeks after surgery for structural and functional analysis using electron microscopy, 10 electrophysiology, 12 and confocal Ca 2+ imaging, 12 as described. The methods are detailed in the Online Data Supplemental Materials.
Results

MiR-24 Suppression Prevented Decompensation but Not Hypertrophy
Compared with that in the sham-operated group, the miR-24 level in isolated ventricular myocytes exhibited a ≈2.5-fold increase in the NC group, but not in the antagomir group ( Figure  1A) , indicating that the upregulation of miR-24 associated with TAC-induced hypertrophy was successfully suppressed by the antagomir treatment.
Echocardiographic measurements ( Figure 1B ) showed that left ventricle hypertrophy developed 4 weeks after TAC surgery in our models ( Figure 1C ). Around 15 weeks later, the fractional shortening became decreased ( Figure 1D ), indicating a transition from compensated to decompensated hypertrophy. Notably, although in vivo antagomir treatment did not interfere with the development of hypertrophy ( Figure 1C ), it did prevent the reduction of fractional shortening ( Figure 1D ), indicating that the transition toward decompensated hypertrophy was effectively prevented by miR-24 suppression.
In Vivo MiR-24 Suppression Protected E-C Coupling in Cardiomyocytes
To examine whether miR-24 suppression protected E-C coupling at the cellular level, we recorded the Ca 2+ transient evoked by whole-cell LCC Ca 2+ current (Figure 2A ) under a condition (resting cardiomyocytes equilibrated in 2 mmol/L extracellular Ca 2+ ), where the SR Ca 2+ load was comparable among all groups (Online Figure II) . In the NC group, TAC induced a significant reduction in Ca 2+ transient amplitude without altering whole-cell LCC Ca 2+ current density ( Figure 2B ), leading to a decreased gain of E-C coupling ( Figure 2C ) and reduced fraction of cell contraction ( Figure 2D ). In contrast, the Ca 2+ transient amplitude ( Figure 2B) , the E-C coupling gain ( Figure 2C ), and the fractional shortening ( Figure 2D ) were well maintained after TAC in the antagomir group, indicating that miR-24 suppression protected the integrity of E-C coupling in hypertrophied cardiomyocytes.
Ca 2+ transients are composed of numerous Ca 2+ sparks evoked by LCC openings. Using unique loose-patch confocal imaging technology, 7, 12 we investigated the effect of the antagomir on LCC-RyR intermolecular Ca 2+ signaling. To visualize single LCC activity, in the form of Ca 2+ sparklets, 7 we included in the pipette solution 20 mmol/L Ca 2+ and 10 μmol/L FPL64176, an LCC agonist. Depolarization of oncell patches evoked 2 distinct populations of local Ca 2+ events ( Figure 3A) : steep, ryanodine-sensitive Ca 2+ sparks from RyRs; and flat, ryanodine-resistant, but nifedipine-sensitive, Ca 2+ sparklets from individual LCCs. 7 With comparable Ca 2+ release duration (time-to-peak), the amplitude of Ca 2+ sparks was significantly lower in the NC group but not in the TAC antagomir group ( Figure 3B ), indicating that the TACinduced decrease of local Ca 2+ release flux was prevented by antagomir treatment. To quantify the fidelity of LCC-RyR coupling, we measured the percentage of the first detectable Ca 2+ sparklets that successfully triggered Ca 2+ sparks during the depolarization. The fidelity was decreased significantly in the NC group but unchanged in the antagomir group ( Figure  3C failed to trigger a Ca 2+ spark (miss index) was increased in the NC group but not in the antagomir group ( Figure 3C , lower). We also quantified LCC-RyR coupling kinetics by the latency from the onset of a Ca 2+ sparklet to the takeoff of a triggered Ca 2+ spark ( Figure 3D ). Exponential fitting of the coupling latency ( Figure 3E ) showed that the time constant for LCC-RyR coupling was prolonged in the NC group but unchanged in the antagomir group ( Figure 3F ). These results indicated that miR-24 suppression effectively prevented the decreased efficiency and slowed kinetics of LCC-RyR signaling in failing heart cells. 12, 18 
MiR-24 Suppression Prevented Structural Rremodeling of E-C Coupling Apparatus
Next, we checked the ultrastructural basis of LCC-RyR communication using transmission electron microscopy. Stereological analysis (Online Figure III) showed that the volume density and the surface area of TTs apparently coupled to SRs were dramatically decreased in the NC group but not in the antagomir group ( Figure 4A ). The increase of bald TTs and decrease of junctional SRs were also suppressed by the antagomir. In failing heart cells, TT-SR junctions were displaced from the Z-line area, exhibiting increased junction-Z distance ( Figure 4B and 4C). 10 The increased junction-Z distance was not observed in the antagomir group ( Figure  4C ). The spatial span of individual TT-SR junctions is one of the determinants of LCC-RyR signaling efficiency. 10 We found that the antagomir prevented the shrinkage of individual junction size ( Figure 4D ). These data indicated that the defects of TT-SR junctions in failing cardiomyocytes were prevented by miR-24 suppression. JP2 is a structural protein maintaining the morphology of TT-SR junctions and efficiency of LCC-RyR signaling. [8] [9] [10] We found that the levels of both JP2 mRNA and protein, showing that LCC Ca 2+ sparklets (blue arrows) triggered RyR Ca 2+ sparks (red arrows) in a probabilistic manner during 70-mV depolarizations from resting potential (RP+70, upper). B, Amplitude (upper) and time-to-peak (lower) of triggered Ca 2+ sparks in sham (187 events), NC (150 events), and antagomir (185 events) groups. C, LCC-RyR coupling fidelity (upper) was indexed by the percentage of the first apparent Ca 2+ sparklet that successfully activated a Ca 2+ spark during a patch depolarization. The miss index (lower) was defined as the percentage of depolarizing pulses that failed to trigger any Ca 2+ spark. The percentages were first determined for each cell, and then averaged in the sham (59 cells), NC (52 cells), and antagomir (62 cells) groups. D, Example of a confocal image (upper) and its time profile (lower) from the antagomir group, illustrating the measurement of LCC-RyR coupling latency from the onset of a Ca 2+ sparklet (blue arrow) to the takeoff of the triggered Ca 2+ spark (red arrow). E, The distributions (bars) and their exponential fits (curves) of coupling latency in sham (109 events), NC (105 events), and antagomir (123 events) groups. F, Comparison of time constants (τ L ) of the LCC-RyR coupling latency among groups. *P<0.05; **P <0.01 vs sham; and ##P<0.01 vs NC. February 15, 2013 which were significantly decreased in the NC group, were unchanged in the antagomir group ( Figure 4E ).
Discussion
E-C coupling becomes defective during the chronic transition from compensated hypertrophy to heart failure. 12, 20 In the present study, we show that in vivo silencing of miR-24 in an aortic-constricted mouse model effectively protects cardiomyocytes from structural/functional disruption of E-C coupling and prevents the transition toward decompensated hypertrophy.
MiR-24 is expressed in cardiomyocytes and many other cell types, and regulates multiple target proteins. [19] [20] [21] [22] We have recently shown that overexpression of miR-24, as observed in heart failure/hypertrophy models, suppresses JP2 expression and leads to defective E-C coupling in cardiomyocytes. 15 In the present study, we show that the JP2 downregulation is prevented by the miR-24 antagomir in TAC mice. As our bioinformatic analysis was not able to identify other miR-24 targets with known function related to E-C coupling, the stabilization of JP2 at least partially explains the protective effects of miR-24 suppression on TT-SR junctions and E-C coupling. Besides E-C coupling, whether other histological/molecular hallmarks of decompensation, such as fibrosis, are altered by miR-24 modulation still needs further in-depth studies.
The pathogenesis of hypertrophy and heart failure involves a variety of intracellular signaling cascades, including the calcineurin-nuclear factor of activated T-cells (NFAT) pathway, the calmodulin-dependent protein kinase pathway, and pathways involving other protein kinases. 23, 24 The NFATc3 pathway controls the miR cluster miR-23a≈27a≈24-2, which is upregulated in hypertrophy. 21, 22, 25 In this cluster, miR-23, but not miR-24 and miR-27, is found essential in the isoproterenol/aldosterone-induced cardiomyocyte hypertrophy. 25 Agreeing with this report, our present study shows that miR-24 suppression in vivo does not prevent TAC-induced hypertrophy. Excitingly, miR-24 suppression does prevent the structural and functional degradation of E-C coupling, indicating that miR-24 upregulation is important in the transition from compensated hypertrophy to heart failure. 
